Synthetic peptide (Human) corresponding to the C terminal domain of RIP140. Peptide available as ab93493.
Our Abpromise guarantee covers the use of ab42126 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||Use a concentration of 4 µg/ml.|
|IHC (PFA fixed)||Use at an assay dependent concentration.|
|IHC-Fr||Use at an assay dependent concentration.|
|ICC/IF||Use a concentration of 5 µg/ml.|
|ChIP||Use at an assay dependent concentration. PubMed: 21360626|